A critique of the fragility index

Lancet Oncol. 2019 Oct;20(10):e551. doi: 10.1016/S1470-2045(19)30582-0. Epub 2019 Sep 30.

Authors

David Bomze¹, Tomer Meirson²

Affiliations

¹ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel. Electronic address: davidbomze@mail.tau.ac.il.
² Drug Discovery Laboratory, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

PMID: 31578993
DOI: 10.1016/S1470-2045(19)30582-0

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents*
Retrospective Studies
Sample Size

Substances

Antineoplastic Agents